101 related articles for article (PubMed ID: 23335086)
1. [Mechanisms, clinical profile and role of prostaglandin and prostamide analogues in antiglaucomatous therapy].
Yu A; Welge-Lüßen U
Klin Monbl Augenheilkd; 2013 Feb; 230(2):127-32. PubMed ID: 23335086
[TBL] [Abstract][Full Text] [Related]
2. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
Bean GW; Camras CB
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
[TBL] [Abstract][Full Text] [Related]
3. Goldmann applanation tonometry and dynamic contour tonometry after treatment with prostaglandin analog/prostamide.
Ang GS; Wells AP
J Glaucoma; 2010; 19(5):346; author reply 347. PubMed ID: 20543630
[No Abstract] [Full Text] [Related]
4. [Effects of reading, exercise and exercise combined with reading on intraocular pressure for patients sustaining primary glaucoma (open angle) or ocular hypertension, both clinically controlled with topic medication].
Medina AM; Lima NV; Santos RC; Pereira MC; Santos PM
Arq Bras Oftalmol; 2007; 70(1):115-9. PubMed ID: 17505730
[TBL] [Abstract][Full Text] [Related]
5. Bimatoprost - a review.
Patil AJ; Vajaranant TS; Edward DP
Expert Opin Pharmacother; 2009 Nov; 10(16):2759-68. PubMed ID: 19874254
[TBL] [Abstract][Full Text] [Related]
6. Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.
Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
J Glaucoma; 2010 Mar; 19(3):199-206. PubMed ID: 19661825
[TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).
Birt CM; Buys YM; Ahmed II; Trope GE;
J Glaucoma; 2010 Sep; 19(7):460-7. PubMed ID: 20051890
[TBL] [Abstract][Full Text] [Related]
9. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
11. [Steroid induced ocular hypertension and glaucoma].
Călugăru D; Călugăru M
Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
[TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
14. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension.
Hommer A
Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609
[TBL] [Abstract][Full Text] [Related]
15. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
Kobayashi H; Kobayashi K
J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
[TBL] [Abstract][Full Text] [Related]
16. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.
Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
Am J Manag Care; 2002 Aug; 8(10 Suppl):S240-8. PubMed ID: 12188166
[TBL] [Abstract][Full Text] [Related]
17. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
Shimmyo M
Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension.
Miglior S; Grunden JW; Kwok K;
Eye (Lond); 2010 Jul; 24(7):1234-42. PubMed ID: 20019759
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Holló G; Thelen U; Teus MA; Quaranta L; Ferkova S; Babić N; Misiuk-Hojlo M; Mikropoulos DG; Kaluzny BJ; Kozobolis V; Januleviciene I; Kóthy P; Camara C; Russo A; Krzyzanowska-Berkowska P; Cieślińska I; Stewart JA; Kristoffersen MS; Nelson LA; Stewart WC
J Ocul Pharmacol Ther; 2011 Oct; 27(5):493-8. PubMed ID: 21790326
[TBL] [Abstract][Full Text] [Related]
20. Switching prostaglandin analogues and 24-hour IOP fluctuations.
Gil-Carrasco F; Turati-Acosta M; Albis-Donado O; Bello-López-Portillo H; Sánchez-Noguera C; Soto-Ortiz K
Arch Soc Esp Oftalmol; 2013 Apr; 88(4):130-3. PubMed ID: 23597641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
